VENKYS (INDIA)
|
VENKYS (INDIA) Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 56.13 | 50.03 | 116.97 | 190.05 | -19.28 |
| CEPS(Rs) | 80.97 | 75.21 | 142.93 | 215.21 | 5.03 |
| DPS(Rs) | 7.00 | 6.00 | 13.00 | 17.00 | - |
| Book NAV/Share(Rs) | 972.67 | 921.82 | 886.49 | 783.98 | 593.62 |
| Tax Rate(%) | 27.74 | 26.04 | 27.25 | 25.76 | 45.35 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 3.30 | 2.64 | 5.55 | 12.47 | -0.65 |
| EBIT Margin(%) | 3.41 | 2.69 | 5.55 | 12.49 | -0.62 |
| Pre Tax Margin(%) | 2.93 | 2.25 | 5.15 | 11.57 | -1.52 |
| PAT Margin (%) | 2.12 | 1.66 | 3.74 | 8.59 | -0.83 |
| Cash Profit Margin (%) | 3.05 | 2.50 | 4.58 | 9.73 | 0.22 |
| Performance Ratios | |||||
| ROA(%) | 3.85 | 3.56 | 8.82 | 15.81 | -1.72 |
| ROE(%) | 5.93 | 5.53 | 14.00 | 27.59 | -3.16 |
| ROCE(%) | 8.45 | 7.78 | 17.90 | 32.10 | -1.77 |
| Asset Turnover(x) | 1.82 | 2.14 | 2.36 | 1.84 | 2.07 |
| Sales/Fixed Asset(x) | 3.69 | 4.34 | 4.60 | 3.42 | 3.97 |
| Working Capital/Sales(x) | 5.77 | 6.25 | 6.94 | 6.69 | 21.85 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.27 | 0.23 | 0.22 | 0.29 | 0.25 |
| Receivable days | 66.95 | 55.81 | 42.67 | 49.12 | 42.20 |
| Inventory Days | 17.97 | 16.42 | 16.71 | 19.29 | 17.92 |
| Payable days | 53.93 | 44.24 | 38.44 | 60.14 | 44.73 |
| Valuation Parameters | |||||
| PER(x) | 27.41 | 28.84 | 18.29 | 8.18 | - |
| PCE(x) | 19.00 | 19.19 | 14.97 | 7.22 | 167.80 |
| Price/Book(x) | 1.58 | 1.57 | 2.41 | 1.98 | 1.42 |
| Yield(%) | 0.45 | 0.42 | 0.61 | 1.09 | - |
| EV/Net Sales(x) | 0.60 | 0.48 | 0.69 | 0.69 | 0.41 |
| EV/Core EBITDA(x) | 13.75 | 13.63 | 10.87 | 5.10 | 95.29 |
| EV/EBIT(x) | 17.52 | 17.88 | 12.50 | 5.57 | -66.36 |
| EV/CE(x) | 1.45 | 1.37 | 1.57 | 1.21 | 0.84 |
| M Cap / Sales | 0.58 | 0.48 | 0.69 | 0.70 | 0.36 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -11.70 | -3.79 | 41.19 | -4.43 | 7.16 |
| Core EBITDA Growth(%) | 8.96 | -46.82 | -33.90 | 2,919.28 | -95.83 |
| EBIT Growth(%) | 12.16 | -53.39 | -37.28 | 2,027.30 | -106.55 |
| PAT Growth(%) | 12.18 | -57.23 | -38.45 | 1,085.69 | -115.60 |
| EPS Growth(%) | 12.18 | -57.23 | -38.45 | 1,085.69 | -115.60 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.12 | 0.14 | 0.15 | 0.16 | 0.36 |
| Current Ratio(x) | 1.97 | 2.02 | 1.99 | 1.74 | 1.21 |
| Quick Ratio(x) | 1.71 | 1.72 | 1.70 | 1.40 | 1.05 |
| Interest Cover(x) | 7.02 | 6.16 | 13.89 | 13.66 | -0.68 |
| Total Debt/Mcap(x) | 0.08 | 0.09 | 0.06 | 0.08 | 0.25 |
Compare Financial Ratios of peers of VENKYS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENKYS (INDIA) | ₹2,483.5 Cr | -4.8% | 4.2% | -7.2% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹15,301.3 Cr | -8.8% | -12.1% | 69.9% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,504.8 Cr | -2.1% | 5.7% | 48.9% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,577.2 Cr | -6.3% | 6.5% | -41.5% | Stock Analytics | |
| INDO US BIOTECH | ₹631.3 Cr | -10.7% | 24.5% | 66.6% | Stock Analytics | |
| TIERRA AGROTECH | ₹392.1 Cr | -1.9% | -1.6% | -31% | Stock Analytics | |
VENKYS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENKYS (INDIA) | -4.8% |
4.2% |
-7.2% |
| SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses
